Atika Capital Management LLC Dexcom Inc Transaction History

Atika Capital Management LLC

$874 Million
Q3 2024

A detailed history of Atika Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Atika Capital Management LLC holds 87,000 shares of DXCM stock, worth $6.96 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

87,000

Previous 87,000 -0.0%

Holding current value

$6.96 Million

Previous $9.86 Million 40.9%

% of portfolio

0.67%

Previous 1.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $1.76 Million - $2.25 Million	-16,000 Reduced 15.53%	87,000 $9.86 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $2.34 Million - $3.85 Million	31,000 Added 43.06%	103,000 $12.8 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $2.67 Million - $4.28 Million	-31,000 Reduced 30.1%	72,000 $6.72 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $794,038 - $924,718	-7,060 Reduced 6.41%	103,000 $13.2 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $3.28 Million - $3.88 Million	-31,575 Reduced 22.29%	110,060 $12.8 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $12 Million - $17.4 Million	141,635 New	141,635 $16 Million
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $877,070 - $1.71 Million	-12,900 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $141,120 - $195,299	-1,500 Reduced 10.42%	12,900 $6.6 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $610,389 - $765,254	4,700 Added 48.45%	14,400 $7.73 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $928,377 - $1.25 Million	8,700 Added 870.0%	9,700 $5.31 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $84,790 - $104,740	1,000 New	1,000 $360,000
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $2.18 Million - $2.93 Million	-28,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $95,510 - $112,950	-1,000 Reduced 3.45%	28,000 $11.5 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $1 Million - $1.69 Million	-16,000 Reduced 35.56%	29,000 $11.8 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $95,580 - $151,260	-2,000 Reduced 4.26%	45,000 $12.1 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $183,100 - $286,450	5,000 Added 11.9%	47,000 $10.3 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $355,300 - $438,000	-10,000 Reduced 19.23%	42,000 $6.27 Million
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $779,520 - $1.09 Million	-28,000 Reduced 35.0%	52,000 $7.79 Million
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $266,665 - $362,710	-9,500 Reduced 10.61%	80,000 $9.53 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $742,225 - $1.03 Million	-27,500 Reduced 23.5%	89,500 $10.7 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $980,700 - $1.54 Million	42,000 Added 56.0%	117,000 $16.7 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $754,220 - $1.08 Million	43,000 Added 134.38%	75,000 $7.12 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $417,920 - $593,280	32,000 New	32,000 $2.37 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account

Atika Capital Management LLC Dexcom Inc Transaction History